Institutions own 37% of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) shares but retail investors control 37% of the company

Key Insights Significant control over Aldeyra Therapeutics by retail investors implies that the general public has more...

Related Keywords

Todd Brady ,Perceptive Advisors ,Vanguard Group Inc ,Aldeyra Therapeutics Inc ,Aldeyra Therapeutics ,Knoll Capital Management ,Vanguard Group ,Institutional Ownership ,Retail Investors ,Shareholders ,Ownership Structure ,Institutional Investors ,Company ,